AI
By
Can Johnson & Johnson’s 6-Point AI Strategy Revolutionize Surgery, Drug Discovery, and Global Patient Care?
Key Highlights From Experimentation to Execution: Focused AI for Measurable OutcomesAfter piloting 900+ generative AI use cases, Johnson…
At VivaTech 2025, Can NVIDIA, Sanofi, and TetraScience Unlock the Full Potential of Scientific AI Despite a 20-Exabyte Data Barrier?
Key Highlights The 20-Exabyte Problem: Data, Not Models, Is the Limiting FactorAt The Rise of Scientific AI panel…
Is AstraZeneca’s $20M AI Hub in Bengaluru the Catalyst for 20 New Medicines by 2030?
Key Highlights Strategic Investment to Scale AI-Driven InnovationAstraZeneca has inaugurated a state-of-the-art Global Hub in Bengaluru with an…
Will Samsung’s Acquisition of Xealth Spark a New Era of AI-Driven Mobile Healthcare in the U.S.?
Key Highlights Samsung Expands into AI Healthcare with Xealth DealSamsung Electronics has announced its acquisition of Xealth, a…
Could Aiforia and Siemens Healthineers Transform Digital Pathology Across Europe With AI?
Key Insights: Strategic Partnership to Expand AI Pathology Aiforia Technologies Plc announced a major collaboration with Siemens Healthineers…
Can Ant Group’s AQ AI Health App Redefine Access to Quality Care for 140 Million Users Across China?
Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…
